Literature DB >> 7827890

Classification of the sequelae of bowel resection for Crohn's disease.

J Cosnes1, V de Parades, F Carbonnel, L Beaugerie, Y Ngo, J P Gendre, A Sezeur, D Gallot, M Malafosse, Y le Quintrec.   

Abstract

A postoperative handicap index designed to predict diarrhoea and malnutrition following bowel resection in patients with Crohn's disease is proposed. The index takes into account the location and extent of resection, and its value can be calculated from operative records. Retrospective (n = 218) and prospective (n = 68) series of patients were studied. Diarrhoea and malnutrition developed in 102 patients (47 per cent) and 13 patients (6 per cent) respectively in the retrospective series, and in 40 (59 per cent) and one (1 per cent) of those in the prospective series. The handicap index correlated with faecal weight and faecal fat in 112 patients tested. Positive and negative predictive values of an index score greater than 20 for the development of diarrhoea, and over 50 for the development of malnutrition, were 0.64 and 0.90, and 0.60 and 0.99 respectively in the retrospective series; values were 0.80 and 0.71, and 0.25 and 1.00 in the prospective series. The postoperative handicap index is a useful tool for predicting the functional consequences of bowel resection for Crohn's disease.

Entities:  

Mesh:

Year:  1994        PMID: 7827890     DOI: 10.1002/bjs.1800811122

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Crohn's disease severity in familial and sporadic cases.

Authors:  F Carbonnel; G Macaigne; L Beaugerie; J P Gendre; J Cosnes
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

2.  Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease.

Authors:  Laurent Peyrin-Biroulet; W Scott Harmsen; William J Tremaine; Alan R Zinsmeister; William J Sandborn; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-04       Impact factor: 11.382

3.  Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.

Authors:  J Cosnes; I Nion-Larmurier; L Beaugerie; P Afchain; E Tiret; J-P Gendre
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

Review 4.  Preventing Collateral Damage in Crohn's Disease: The Lémann Index.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  J Crohns Colitis       Date:  2016-01-07       Impact factor: 9.071

5.  Development of the Crohn's disease digestive damage score, the Lémann score.

Authors:  Benjamin Pariente; Jacques Cosnes; Silvio Danese; William J Sandborn; Maïté Lewin; Joel G Fletcher; Yehuda Chowers; Geert D'Haens; Brian G Feagan; Toshifumi Hibi; Daniel W Hommes; E Jan Irvine; Michael A Kamm; Edward V Loftus; Edouard Louis; Pierre Michetti; Pia Munkholm; Tom Oresland; Julian Panés; Laurent Peyrin-Biroulet; Walter Reinisch; Bruce E Sands; Juergen Schoelmerich; Stefan Schreiber; Herbert Tilg; Simon Travis; Gert van Assche; Maurizio Vecchi; Jean-Yves Mary; Jean-Frédéric Colombel; Marc Lémann
Journal:  Inflamm Bowel Dis       Date:  2010-11-28       Impact factor: 5.325

6.  Factors affecting outcomes in Crohn's disease over 15 years.

Authors:  Jacques Cosnes; Anne Bourrier; Isabelle Nion-Larmurier; Harry Sokol; Laurent Beaugerie; Philippe Seksik
Journal:  Gut       Date:  2012-03-02       Impact factor: 23.059

7.  Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor.

Authors:  Raffaella Maria Gadaleta; Oihane Garcia-Irigoyen; Marica Cariello; Natasha Scialpi; Claudia Peres; Stefania Vetrano; Gionatha Fiorino; Silvio Danese; Brian Ko; Jian Luo; Emanuele Porru; Aldo Roda; Carlo Sabbà; Antonio Moschetta
Journal:  EBioMedicine       Date:  2020-04-05       Impact factor: 8.143

8.  Longer small bowel segments are resected in emergency surgery for ileocaecal Crohn's disease with a higher ileostomy and complication rate.

Authors:  V Celentano; D P O'Leary; A Caiazzo; K G Flashman; F Sagias; J Conti; A Senapati; J Khan
Journal:  Tech Coloproctol       Date:  2019-10-29       Impact factor: 3.781

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.